Nicholas G Panos

Learn More
The emergence of dabigatran, rivaroxaban and apixaban has changed the approach to anticoagulation for patients worldwide. Continued approval of novel oral anticoagulants (NOAC) for non-valvular atrial fibrillation and venous thromboembolism will result in increasing use of these medications over warfarin. Morbidity and mortality of anticoagulant related(More)
We study the information content and consequences of third-party voting advice issued during proxy contests. Focusing on recommendations by a leading proxy advisor, we find significant abnormal stock returns around the dates recommendations become public. The economic interpretation is that voting advice conveys new information to the market. To investigate(More)
  • 1